第六届中药临床药理学术会议暨中药新药临床研究与评价学术研讨会会议纪要
出处
《中药新药与临床药理》
CAS
CSCD
2005年第1期76-76,共1页
Traditional Chinese Drug Research and Clinical Pharmacology
二级参考文献17
-
1Lim CS, Baumann CT, Htun H, et al. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol Endocrinol, 1999,13(3):366-375.
-
2Hovland AR, Powel RL, Takimoto GS, et al. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform, but not the B-isoform, of human progesterone receptors. J Biol Chem,1998,273:5455-5460.
-
3Clemm DL, Sherman L, Boonyaratanakornkit V, et al. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol, 2000,14:52-65.
-
4Giangrande PH, Kimbrel EA, Edwards DP, et al. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactors binding. Mol Endocrinol, 2000,20:3102-3115.
-
5Tetel MJ, Giangrande PH, Leonharbt SA, et al. Hormone dependent interaction between the amino- and carboxyl-terminal domains of the progesterone receptor in vitro and in vivo. Mol Endocrinol,1999,13:910-924.
-
6Truss M, Bartsch J, Beato M. Antiprogestins prevent progesterone receptor binding to hormone responisive elements in vivo. Proc Natl Acad Sci USA, 1994.91 (24):11333-11337.
-
7Takimoto GS, Tasset DM, Eppert C, et al. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc Natl Acad Sci USA, 1992,89:3050-3054.
-
8Beck CA, Zhang Y, Weigel NL, et al. Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor. J Biol Chem, 1996,271(2):1209-1217.
-
9Vegeto E, Allan GF, Schrader WT, et al.The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell,1992,69:703-713.
-
10Xu J, Nawaz Z, Tsai SY. et al. The extreme C terminus of progesterone receptor contains a transcriptional receptor domain that functions through a putative corepressor. Proc Natl Acad Sci USA,1996,93(22):12195-12199.
共引文献7
-
1蔡任飞,屠爽,刘建华.不全性药物流产药物保守治疗(附149例病例分析)[J].中国医师杂志,2004,6(7):896-897. 被引量：5
-
2杨阳,雷秀兵.米索前列醇阴道置药的新进展[J].现代医药卫生,2005,21(8):951-951. 被引量：5
-
3张华英.米索前列醇在终止早期妊娠中的应用[J].实用临床医学（江西）,2005,6(7):161-162. 被引量：1
-
4胡翠兰.149例药物流产的观察及护理[J].护理与康复,2009,8(9):750-751. 被引量：2
-
5刘晓明.2种方法治疗药物流产不全疗效比较[J].现代中西医结合杂志,2012,21(23):2545-2546. 被引量：16
-
6孙温冬.米非司酮用于药物流产的护理体会[J].基层医学论坛,2013,17(6):799-800.
-
7于凤英.米非司酮药物流产与继后妊娠产后出血的研究[J].世界最新医学信息文摘,2013,13(4):155-155. 被引量：1
-
1黄欣.WHO对传统医学的研究与评价方法论的限定草案[J].国外医学（中医中药分册）,1999,21(4):58-64. 被引量：3
-
2《创新药物药代动力学研究与评价》征订[J].中国临床药理学杂志,2008,24(6):569-569.
-
3第六届中药临床药理学术会议暨中药新药临床试验基地学术交流会通知[J].中药新药与临床药理,2004,15(2):89-89.
-
42013年中药上市后再评价国际大会、世界中医药学会联合会中药上市后再评价专业委员会成立大会暨中华中医药学会中药临床药理分会年会撷影[J].中国中药杂志,2014,39(18).
-
5张丽.体外诊断试剂临床研究的基本要点[J].中国生物制品学杂志,2006,19(4):437-437.
-
6重庆医科大学病毒性肝炎研究所招聘启事[J].中华肝脏病杂志,2004,12(6):352-352.
-
7张丰聪.中医学术流派研究与评价体系的建立及应用[J].山东中医药大学学报,2016,40(6).
-
8郭永松,茅晓延.对医学人文社会科学综合课程改革的初步评价[J].医学与哲学,2001,22(1):48-50. 被引量：4
